Compounding Pharmacy $6.1m EBITDA / $73m Gross Revenue - (Confidential)
Large-Scale Compounding Pharmacy with Strong EBITDA
On NextCompany since August 28, 2026 (today)
Location undisclosed
Business overview
The compounding pharmacy achieves $73,000,000 in gross revenue. It delivers $6,100,000 in EBITDA.
Who is a good fit for this business
- Buyers active in the pharmaceutical or health sector.
- Acquirers equipped to manage large inventory levels.
- Firms pursuing high-EBITDA operations with substantial FF&E.
Details
Frequently Asked Questions
The compounding pharmacy reports $73,000,000 in gross revenue. EBITDA reaches $6,100,000.